DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 205 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362 | +21.9% | 24,484 | +6.6% | 0.03% | +21.7% |
| Q2 2023 | $297 | -1.3% | 22,959 | -25.3% | 0.02% | +4.5% |
| Q1 2023 | $301 | -16.6% | 30,717 | -9.4% | 0.02% | -26.7% |
| Q4 2022 | $361 | -99.9% | 33,893 | -17.1% | 0.03% | -25.0% |
| Q3 2022 | $427,000 | +11.8% | 40,888 | +34.9% | 0.04% | +14.3% |
| Q2 2022 | $382,000 | +28.2% | 30,319 | +10.2% | 0.04% | +250.0% |
| Q1 2022 | $298,000 | +63.7% | 27,513 | +112.5% | 0.01% | +66.7% |
| Q4 2021 | $182,000 | +28.2% | 12,946 | -10.6% | 0.01% | -50.0% |
| Q1 2021 | $142,000 | – | 14,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |